Effect of removal of AuraOnceTM laryngeal mask in awake or deep anaesthesia: a randomized controlled trial by Ombaka, Ronald et al.
Effect of  removal of   AuraOnceTM laryngeal mask  in awake or 
deep anaesthesia: a randomized controlled trial
Ronald Ombaka, Vitalis Mung’ayi, David Nekyon, Samina Mir 
(Anaesthesia), Department of  Anaesthesia, Aga Khan University, East Africa
Emails:
ronald.ombaka@aku.edu; vitalis.mung’ayi@aku.edu; david.nekyon@aku.edu; samina.mir@aku.edu
Abstract
Background: The manufacturer Ambu® recommends that the AuraOnce™ laryngeal mask be removed once the patient is 
fully awake. Studies have shown benefit in removal of  the laryngeal mask airway while a patient is deeply anaesthetized. Current 
evidence is inconclusive, as to which approach is preferable and safer in adults.
Methods: one hundred and sixteen adult patients were randomly assigned to two groups of  58. For the deep arm;  The  Au-
raOnceTM laryngeal mask was removed after attaining an end tidal minimum alveolar concentration of  Isoflurane of  1.15%. 
Occurrence of  airway complication(s) (One or more of  the following; Airway obstruction requiring airway manipulation; La-
ryngospasm; Desaturation to 90% or less on pulse oximetry) was noted until the subject was fully awake (appropriate response 
to command) in the post-anaesthesia care unit. For the awake arm; The AuraOnceTM laryngeal mask was removed on attaining 
an end tidal minimum alveolar concentration of  Isoflurane of  <0.5% and an appropriate response to command or obtaining 
appropriate response to command irrespective of  end tidal concentration. Occurrence of  airway complication(s) in theatre and 
post anaesthesia care unit was recorded. Time to theatre exit was recorded for both groups.
Results:  Baseline demographic characteristics were similar between the groups. More airway complications were encountered 
in the Deep arm - 13 (22.4%) relative to the Awake arm -5 (8.6%), this was found to be statistically and clinically significant, P 
value P=0.040, odds ratio 3.0622; 95% CI, 1.0139 to 9.2483.
Conclusion: The removal of  the  AuraOnceTM laryngeal mask while the patient is still deeply anaesthetised is not as safe as or 
safer than awake removal.
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Introduction
The Laryngeal Mask Airway (LMA) is a supra-glottic air-
way device that was invented in 1981 by Archie Brain, an 
Anaesthesiologist1. Its invention marked a turning point 
in airway management in anaesthesia as it offered a con-
venient bridge between the use of  an endotracheal tube 
and facemask ventilation. Several advantages have been 
cited for its use as compared to the endotracheal tube 
or the facemask, as an airway management option given 
the appropriate indication. A meta-analysis by J. Brima-
combe et al found that the LMA had thirteen advantages 
over the endotracheal tube and four over the face mask as 
techniques of  airway management2.
Of  the advantages, ease of  use is a prominent feature 
of  the LMA. This relative ease of  use and safety pro-
file has led to the utilization of  an estimated 200 million 
LMAs globally as of  2013 3. At The Aga Khan University 
Hospital, Nairobi (the site of  this study), records availed 
by the hospital showed that out of  the 9138 general an-
aesthesia procedures carried out in the year 2015, 2032 
(21.8%) were performed using the LMA. The utilization 
of  the LMA can be anticipated to increase given the cur-
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rent use of  the device in procedures previously deemed 
as contraindications. For instance, several publications re-
port use in surgery performed in prone position; airway 
surgery such as adeno-tonsillectomy and laparoscopy  
The LMA can be considered to be a relatively new in-
vention, as such, certain aspects of  its use remain unset-
tled and research towards clarifying and improving these 
aspects is ongoing. Whether to remove the LMA when 
patient is “awake” (appropriate response to command) or 
“deep” (anaesthetized) is one such area.
At our institution, the Ambu® AuraOnce™ laryngeal 
mask, (ALM), is the design variant most utilized. The 
Ambu® ALM features a special 70° curve that careful-
ly replicates natural human anatomy. Moulded directly 
into the tube for additional safety, the unique shape of  
the mask makes correct insertion fast and easy without 
putting extra stress on the upper jaw. The manufactur-
er of  the ALM, Ambu®, recommends that the ALM be 
removed once the patient is fully awake and protective 
airway reflexes are active7. This recommendation was also 
put forth by the inventor of  the LMA,  Archie Brain1 
in 1983. There appears to be no objective evidence in 
support of  these recommendations, as such, use of  the 
LMA over the past 25 years has led to several studies to 
substantiate this recommendation.
This gap in knowledge is summarized in the conclusion 
of  a Cochrane systematic review by Mathew P.J. et al, 
that current evidence does not show superiority of  either 
approach8. They also noted that the quality of  currently 
available evidence was low.
An internet search also revealed several discussion fo-
rums/blogs on the same topic that yielded no conclusive 
evidence cited or consensus from proponents of  either 
approach9,10.
The variation in individual practice is based primarily on 
possible complications associated with either approach. 
Deep removal being associated with possibility of  airway 
loss (soft tissue obstruction, laryngospasm) and subse-
quent desaturation and hypoxia. Whereas awake removal 
being associated with the possibility of  coughing, retch-
ing , agitation on emergence ,increased incidence of  gas-
tric content regurgitation , laryngospasm, biting hence 
occluding LMA11. Why users opt for either technique is 
not clearly delineated, as both approaches seem to have 
several undesirable outcomes with unspecified frequency.
This study set out to determine the proportion of  airway 
complications occurring in awake versus deep (anaesthe-
tized) patients undergoing anaesthesia. The ultimate aim 
was to distinctly quantify the proportion of  airway compli-
cations associated with either approach thus aid decision 
making on safe use of  the ALM. Our research question 
was: is there a difference in proportion in the occurrence 
of  airway complications between spontaneously breath-
ing adults patients when the ALM is removed deep ver-
sus awake following Isoflurane general anaesthesia? We 
hypothesized that there is no difference in the proportion 
of  airway complications in spontaneously breathing adult 
patients when the ALM is removed deep or awake follow-
ing isoflurane general anaesthesia. Our primary objective 
was to compare the impact of  having AuraOnce™ laryn-
geal mask removal deep versus awake on the occurrence 
of  airway complications following general anaesthesia in 
spontaneously breathing adult patients. Our secondary 
objectives were to compare the impact of  deep versus 
awake  AuraOnce™ laryngeal mask   removal on anaes-
thesia theatre turn- around time and the incidence of   air-
way obstruction requiring airway manipulation; laryngo-
spasm; desaturation to <90% on pulse oximetry among 
patients where the AuraOnce™ laryngeal mask   is re-
moved deep and awake.
Methods
Approval to conduct the study was sought and obtained 
from the Aga Khan University Research Ethics Commit-
tee prior to initiating the study. The study was carried out 
between February 1 2017 and May 31 2017. Participant 
flow diagram is shown in figure 1. It was a prospective 
randomized control trial conducted at the Aga Khan 
University Hospital, Nairobi. This is a 300 bed private 
not-for-profit institution that provides tertiary and sec-
ondary level health care services. We included all ASA I 
and II patients between 18 years- 65 years scheduled to 
receive general anaesthesia with a laryngeal mask airway 
(as the airway management device) for low to moderate 
risk, elective surgery lasting less than two hours as per 
protocol. Reasons for exclusion from the study were:
 
1. Active/ongoing history of  upper and or lower re-
spiratory tract infection/disease
2. Patients with a difficult AuraOnce™ laryngeal 
mask   insertion (defined as greater than two attempts) 
3. Patients with severe gastroesophageal reflux dis-
ease
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4. Patients with a symptomatic hiatus hernia
5. Patients with a BMI> 40kg/m2
6. History of  Obstructive sleep apnoea
7. Patients in whom muscle relaxants were to  used
8. Patients with Mallampati class 3 and 4
9. Patients who did not give consent
10. Patients who did not understand English or Swa-
hili
11. Patient with psychiatric disease
 
No study reviewed/found in literature was similar or 
methodologically congruous with this study. Proportions 
that may have been drawn from the aforementioned sys-
tematic review are mostly from paediatric studies. Given 
the marked inherent anatomical and physiological differ-
ences of  the adult airway vis-à-vis the paediatric airway 
it was deemed imprudent to draw proportions of  airway 
complications from paediatric studies. The remaining 
adult studies markedly differed in methodology and pri-
mary objective thus proportions from those studies were 
ruled out as well. For instance the study by Nunez et al 
(over and above our questions about the methodology 
of  this study) had a 3.03% incidence of  airway compli-
cations in the awake arm versus 51.5% incidence in the 
deep arm and the study by Gataure et al showed an in-
cidence of  54% airway complications in the awake arm 
versus 20% in the deep arm9,11
The difference in these proportions are 48.5% and 34% 
respectively. The study by Gataure concedes that the inci-
dence of  complications in the awake arm were unusually 
high and possibly caused by a methodological flaw. As for 
Nunez’s study the remarkably high incidence of  airway 
complications is the deep arm was due to deliberate delay 
in placing the Guedel airway, thus markedly exaggerating 
complication incidence in that arm. Lastly the observa-
tional study by Hseih et al found no airway complication 
in all their patients (this study only looked at removal of  
the LMA while patients were deep)13.
Given evaluation of  above data, the proportions drawn 
from those studies to calculate the sample size would 
have probably yielded a type II error, also bearing in mind 
the small sample sizes utilized in these studies. The Aga 
Khan University, Nairobi, Scientific committee therefore 
advised that we consult the anaesthesia department fac-
ulty to advice on probable proportions based on their 
clinical experience. A difference of  25% was thus settled 
upon by consensus after reviewing the above studies and 
local practice.
We therefore resorted to expert opinion based on lack of  
appropriate evidence in this field of  study.
The following sample size calculation formulae were 
used:
 
 
 
Where;
P0 = Probability of  airway complications in the control 
group (Awake arm = 0.25)
P1 = Probability of  airway complications in the experi-
mental group (Deep “anaesthetized” arm = 0.50)
m = Ratio of  controls to experiment subjects (=1).
Z α = normal deviate corresponding to a type I error of  
0.05 or 95% CI in a two tail test = 1.96
Z β = normal deviate corresponding to a Type II error of  
20% equivalent to power 0.8 = 0.842
n = 116 (58 in each arm)
A sample size of  116 patients was drawn to demonstrate 
a 25% difference in the occurrence of  airway complica-
tions between patients in whom the  ALM  was removed 
awake (appropriate response to command) versus in those 
whom the ALM   was removed deep (anaesthetized).
The study was powered to 80% with an alpha of  5%.
Patients were recruited from the day-care unit. Patients 
were informed of  the nature of  the study, screened for 
eligibility and recruited if  eligible. Eligible patients had 
verbal explanations on the purpose and nature of  the 
study. The patients who gave written informed consent 
were enrolled into the study. Our statistician developed a 
simple random allocation sequence using a computer al-
gorithm. Each of  the random numbers were sequentially 
assigned to either; Awake arm: Green sticker; Deep arm: 
Red sticker. The statistician serialized envelops to corre-
spond to the random allocation sequence and insert the 
green and red stickers in them. Patients who consented 
for the study had the serialized envelop attached to their 
file. The research assistant(s) opened the envelope and 
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knew the group allocation and attached the sticker on the 
patient data collection tool. Blinding to the interventions 
was technically not possible for the study.
Once the patient was on the theatre table, ASA recom-
mended14 monitoring set up (i.e. capnography, pulse 
oximetry, temperature, electrocardiography and non-in-
vasive blood pressure monitoring on Mindray Wato Ex-
65 monitor) applied and baseline vital signs measurement 
taken. Intravenous access was obtained using a gauge 18 
- 20 cannula. The patient was then pre-oxygenated at 6 
litres oxygen flow rate for 3 minutes.
Induction was standardized as follows; Propofol 2 mil-
ligrams per kilogram IV (this was titrated to effect as is 
our standard practice, to avoid inadvertent adverse ef-
fects such as hypotension and bradycardia given variable 
patient response) and Isoflurane initiated at 2% on the 
vaporizer; appropriate size ALM was inserted using the 
classical technique, and inflated to a maximum volume ac-
cording to size as per manufacturers recommendation7,15. 
Placement confirmation was by auscultation and capnog-
raphy and the ALM was then secured. Patients were man-
ually ventilated until spontaneous breathing resumed (no 
mechanical ventilation was carried out as it was thought 
that this may confound outcome because resumption of  
spontaneous breathing at the end of  surgery may have be 
delayed).
Opioid use portended to be a confounder on airway com-
plications, as such, standardization was to be attained by 
administering the opioid at beginning of  surgery and at 
recommended dosage i.e. Pethidine 1 milligrams per ki-
logram or Morphine 0.1mg/kg of  Fentanyl 1 to 2 mcg/
kg. These doses were guided by the potential pain associ-
ated with the procedure range in which the ALM is used. 
Routine use of  traditional non-steroidal anti-inflamma-
tory drugs as well as paracetamol was applied if  there 
were no contraindications. Opioids dosage was adjusted 
as per patient requirements and deviation from the proto-
col noted. Suction if  applied was documented in the data 
collection tool. All patients in the deep arm were to be 
suctioned on removal of  the ALM.
The end of  surgery was represented by the point marked 
by end tidal of  1 MAC (1.15 for Isoflurane) as the anaes-
thetist dialled down Isoflurane anticipating end of  proce-
dure. At that point (end tidal of  1.15% Isoflurane) a timer 
was started. The timer would be stopped once the patient 
existed the theatre door.
For the Deep arm of  the study; Isoflurane vaporizer was 
turned off; Oxygen dialled to 100% at 6 litres per minute 
and on attaining an end tidal concentration of  1.15% Iso-
flurane, the ALM   was removed (without deflating cuff) 
and an appropriate sized oropharyngeal airway placed 
and the patient positioned in “sniffing position”; a Hud-
son mask was then be placed at 6 litres oxygen flows. At 
the discretion of  the anaesthetist, the patient exited the 
operating theatre in transit to the post anaesthesia care 
unit (PACU).
For the awake arm of  the study; Isoflurane would be 
turned off; oxygen dialled to 100% at 6 litres flow rate; 
on attaining an end tidal concentration <0.5% Isoflurane 
and an appropriate response to command (as defined) the 
ALM  was removed, however, if  the patient was noted to 
be waking up prior to attaining an end tidal of  < 0.5% 
and  had an appropriate response to command then the 
ALM  was withdrawn irrespective of  end tidal concentra-
tion of  Isoflurane a Hudson mask would then be placed 
and oxygen administered at flows 6 litres flow rate. At the 
discretion of  the anaesthetist the patient exited the oper-
ating theatre in transit to the PACU.
Intra-operative and post-operative data was collected by 
trained research assistants and PACU nurses using a data 
collection form. This continued until the patient was fully 
awake and responding appropriately to command (as de-
fined) for both groups from end of  surgery (as defined).
Parameters of  interest were: Airway obstruction (defined 
as need for airway manipulation); laryngospasm; desatu-
ration to 90% or less on pulse oximetry. The composite 
all the parameters was defined as airway complication(s).
All the raw data in this study was filed in suitable box file 
and flash disk which were kept locked in the principal in-
vestigator’s locker. All data sheets<="" span="" style="-
font-family: "Times New Roman";">were checked for 
completeness prior to filing.
Categorical variables were summarized using frequency 
and percentages while continuous variables were summa-
rized using descriptive statistics i.e. means. Pearson Chi 
Square test was carried out to test the difference in pro-
portions between the incidence of  airway complications 
in the deep arm and awake arm following  ALM   remov-
al.  The secondary outcomes yielded continuous data i.e. 
time it takes to exit theatre. The Mann Whitney test was 
used for the means of  the time to exit theatre for deep 
and awake ALM   removal as the data was non parametric 
in distribution. All data analysis was done at 95% level of  
significance using STATA version 15.
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Results
A total of  135 subjects were recruited, 19 were excluded 
and 116 proceeded into the later part of  the study, 58 
subjects randomized in each arm. No drop outs during 
collection or analysis were encountered. There was no re-
markable difference between the participants in the two 
arms of  the study as shown in table 1.There were 5 out 
of  58 patients in the awake arm who developed airway 
complications (as per definition) and 13 out of  58 pa-
tients in the deep arm who developed airway complica-
tions (as per definition) as shown in table 2.
Table 1. Baseline characteristics of patients between awake and deep arm 
 
  Arm   
p-value Awake (n=58) Deep (n=58) 
Age 
18 – 27 8 13   
  
0.405 
28 – 37 18 23 
38 – 47 16 12 
48 – 57 14 8 
58 – 67 2 2 
Sex 
Male 19 15   
0.415 Female 39 43 
Specialty 
Gynaecology 2 11   
  
0.051 
General Surgery 46 36 
Orthopaedics 9 9 
Urology 1 2 
  
Duration of surgery (mins) 
<=30 9 11   
  
  
0.74 ◊ 
31 – 60 36 24 
          61 -  90 11 15 
91 -  120 2 6 
121 - 150 0 0 
151 - 180 0 1 
181 - 210 0 1 
Mean duration 51.29 (±19.432)  60.31 (±33.307)  0.61  
Opioid use 
Fentanyl 31 27   
  
  
0.94 ◊ 
Tramadol 2 1 
Morphine 14 10 
Pethidine 24 29 
Remifentanyl 0 1 
Notes: 
 Pearson Chi Square test was applied 
◊ Yates' correction p-value 
 Mann Whitney U-test was applied 
P values of less than 0.05 was considered statistically significant. 
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Table 2:  Comparison of occurrence of airway complication between awake arm and deep arm 
 
  Airway Complication (as per definition) Total 
Yes 
n (%) 
No 
n (%) 
Study arms Awake 5(8.6) 53(91.4) 58 
Deep 13(22.4) 45(77.6) 58 
Total 18 98 116 
  χ2 (1) = 4.209, P value 0.040   
Notes: 
 Pearson Chi Square test was applied 
P values of less than 0.05 was considered statistically significant. 
  
The mean theatre exit time (as measured from the time 
1 MAC of  isoflurane was noted at the end of  surgery) 
for the awake arm of  the study was 12.29 minutes (± 
3.637) and for the deep arm of  the study was 7.72 min-
utes (± 5.730) as shown in table 3. There were  5(8.6%) 
patients out of  58 in the awake arm who developed air-
way obstruction requiring airway manipulation compared 
to 13(22.4%) patients out of  58 in the deep arm who de-
veloped airway obstruction requiring airway manipulation 
as shown in table 4.
None of  the patients in the awake arm developed laryn-
gospasm, compared to 2 (3.4%) patients out of  58 who 
developed laryngospasm in the deep arm as shown in ta-
ble 5. None of  the patients in the awake arm were noted 
to have desaturated to less than <90% on pulse oximetry 
after the ALM was removed, compared to 2 (3.4%) pa-
tients out of  58 in the deep arm who did developed de-
saturation to <90% on pulse oximetry as shown in table 
6.
Table 3:  Comparison of mean duration of theatre exit time between awake arm and deep arm 
 
  Mean theatre exit time in minutes P value 
Study arms Awake Deep   
 12.29(± 3.637) 7.72(± 5.730) 0.0001  
Notes: 
 Mann Whitney U-test was applied ( z score = 6.424452, z critical {5% two tailed} =1.959964, p value < 
0.0001) 
P values of less than 0.05 was considered statistically significant. 
  
  
Table 4:  Comparison of occurrence of airway obstruction requiring airway manipulation  
between awake arm and deep arm 
 
  Obstruction Total 
Yes 
n (%) 
No 
n (%) 
Study arms Awake 5(8.6) 53(91.4) 58 
Deep 13(22.4) 45(77.6) 58 
Total 18 98 116 
  χ2 (1) = 4.209, P value 0.040   
Notes: 
 Pearson Chi Square test was applied 
P values of less than 0.05 was considered statistically significant. 
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 Table 5:  Comparison of occurrence of laryngospasm between awake arm and deep arm 
 
  Laryngospasm Total 
Yes 
n (%) 
No 
n (%) 
Study arms Awake 0(0) 58(100) 58 
Deep 2(3.4) 56(96.6) 58 
Total 2 114 116 
  χ2(1) = 2.035, P value  0.154   
Notes: 
 Pearson Chi Square test was applied 
P values of less than 0.05 was considered statistically significant. 
  
Table 6:  Comparison of occurrence of desaturation to <90% on pulse oximetry between 
awake arm and deep arm 
 
  Desaturation Total 
Yes 
n (%) 
No 
n (%) 
Study arms Awake 0(0) 58(100) 58 
Deep 2(3.4) 56(96.6) 58 
Total 2 114 116 
  χ2(1) = 2.035, P value 0.154   
Notes: 
 Pearson Chi Square test was applied 
P values of less than 0.05 was considered statistically significant. 
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Discussion
The key finding of  this study was that there was a statis-
tically significant difference in the occurrence of  airway 
complication (defined as - One or more of  the following; 
airway obstruction requiring airway manipulation; laryn-
gospasm; desaturation to 90% or less on pulse oximetry) 
between the awake (defined as ‘MAC awake’ - Alveolar 
concentration at which 50% concentration} for the com-
monly used volatile agents) arm and deep (at-least 1 MAC 
-Minimum alveolar concentration of  Isoflurane) arm.
As regards airway obstruction requiring airway manipu-
lation fewer patients in the awake arm developed airway 
obstruction requiring airway manipulation compared to 
those in the deep arm. This was found to be statistically 
significant p = 0.040. As regards laryngospasms, none of  
the patients in the awake arm developed laryngospasm, 
compared to 2/58(3.4%) patients who developed laryn-
gospasm in the deep arm. This was found not to be sta-
tistically significant (p = 0.154). There was a similar con-
clusion with the latter as regards desaturation to <90% 
on pulse oximetry as the proportions were identical and 
thus p = 0.154.
This study found that there was a statistically significant 
difference (p < 0.0001) in the mean theatre exit time be-
tween the awake arm, 12.29 minutes (± 3.637) and the 
deep arm, 7.72 minutes (± 5.730).
The primary outcome results of  this study thus reject the 
null hypothesis that there is no difference in the propor-
tions of  airway complications in spontaneously breathing 
adult patients when the laryngeal mask airway is removed 
deep or awake following isoflurane general anaesthesia. 
There was a significant difference in complications, with 
the deep arm show more adverse outcome.
The main finding of  the study contrasts with the con-
clusion in the systematic review by Mathews and col-
leagues,8 that there is no superiority in either approach. 
The awake approached showed significantly less adverse 
outcomes statistically. Clinically, this study set out to have 
a 25% difference between the two arms be considered 
as clinically significant. The difference between the two 
arms was 13.8%, which did not surpass our set threshold. 
Despite this, the airway complications studied are critical 
events that portend adverse sequelea if  unchecked. As 
such, it would be imprudent to disregard this finding as 
clinically insignificant, also considering that the calculated 
odds ratio was 3.0622; 95% CI, 1.0139 to 9.2483.
The study by Gataure et al11 had a contrary conclusion 
to this study i.e. deep (anaesthetized) LMA removal was 
associated with less airway complications compared to 
awake LMA removal. Gataure et al found a complication 
incidence of  20% in the deep arm and 54% in the awake 
arm (Total of  66 patients). The authors (Gataure et al) 
contend that the markedly high proportion of  compli-
cations in the awake group may have been due to lack 
of  familiarity of  PACU nurses with the LMA who sub-
sequently ended up removing the LMA before patient 
was actually truly awake. This is in contrast to this study, 
where the awake arm had complication incidence of  
8.6%. This marked reduction in incidence may be due 
to the fact that the ALM in this study was removed in 
theatre by an anaesthetist (rather than PACU by a nurse). 
Also the seemingly more objective and standard point of  
assessing wakefulness i.e. on attaining an end tidal con-
centration <0.5% Isoflurane and an appropriate response 
to command (as defined) may have aided in achieving 
the remarkably lower incidence of  complications in the 
awake arm of  this study relative to Gataure et al’s study. 
As regards complications in the deep arm, Gataure et al 
study looked at coughing, biting, retching, vomiting, ex-
cess saliva, Airway obstruction. The only comparable pa-
rameter with this study was airway obstruction of  which 
Gataure’s study had zero occurrence, this differs from 
our incidence of  22.4%. This is possibly because the pa-
tients in Gataure’s study were recovered in the lateral po-
sition compared to this study in which participants were 
recovered in the supine position.
In contrast to the only other adult study that specifically 
sought a difference in airway complications during deep 
versus awake LMA removal by Nunez et al12, this study 
had a far lower complication rate in the deep arm (17.2% 
relative to 51.5% in Nunez’s study). This may have been 
due to a difference in methodology, whereby in this study 
a Guedel airway was placed immediately after removing 
the ALM in the deep arm as compared to the Nunez 
study protocol, where the Guedel airway was put only if/
when airway obstruction occurred. In the author’s opin-
ion Nunez’s protocol was counterintuitive, as the effects 
of  volatile agents on muscle tone (i.e. reduction in tone) 
would predispose the patient to airway obstruction. This 
may explain the higher complication rate in the deep arm 
of  Nunez’s study. The awake arm of  Nunez’s study is by 
and large comparable to this study’s results (8.6% relative 
to 6.1% in Nunez’s study). This similarity in incidence 
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may lend credence to the use of  a single, objective end 
point to define appropriate response to command, as il-
lustrated in Nunez’s study as well as this study. Both these 
studies utilized opening mouth to command as a marker 
of  wakefulness/appropriate response to command.
As compared to the study by Heidari et al16 this study 
showed that depth of  anaesthesia may possibly affect 
the occurrence of  airway complications contrary to what 
Heidari et al found.
Baird et al study had remarkably high occurrence of  air-
way complications in both arms17, this may be inferred to 
be due to lack of  clear specified end points, also no exclu-
sions may have led to recruitment of  patients who were 
already at risk of  upper airway obstruction. The results 
of  Baird et al’s study relative to this on show that patient 
selection is critical irrespective of  whether the LMA is 
removed deep or awake.
As per the literature review it is worth noting that this 
is the only study to our knowledge where Isoflurane has 
been used as the sole volatile anaesthetic agent to exam-
ine the impact of  deep versus awake ALM  removal on 
airway complications. Also, the clear definition of  the ob-
jective end points used to define ‘deep’ and ‘awake’ makes 
the study reproducible in contrast to the aforementioned 
studies and possibly resulted in the significantly less oc-
currence of  airway complications in both the awake arm 
and the deep arm of  the study. Therefore, this study adds 
unique knowledge with regards to the use of  laryngeal 
mask airway as a supra-glottic airway device during gen-
eral anaesthesia.
Limitations
This study was relatively small and this may affect the 
generalizability of  the results obtained from this study. 
The method of  randomisation chosen was progressively 
less random as the number of  envelopes reduced, this af-
fected the quality of  the recruitment. We did not use ob-
jective monitoring like Bispectral Index Monitoring (BIS) 
or Entropy in our deep or awake arm since they were not 
readily available.
Conclusion
On the basis of  the results of  this study, it can be con-
cluded that there is a difference in the proportions of  
airway complications in spontaneously breathing adult 
patients when the laryngeal mask airway is removed deep 
or awake following Isoflurane general anaesthesia. There-
fore, the removal of  the ALM  while the patient is deep 
(anaesthetized) is not as safe as or safer than awake re-
moval of  the  ALM   as recommended by the manufac-
turer, Ambu®, and also recommended by Archie Brain in 
the Intavent laryngeal mask airway manual. Therefore, in 
cases where it is desirable to remove the laryngeal mask 
airway while the patient is deep, extra vigilance is required 
in view of  the increased potential for adverse airway com-
plications.
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